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Background 
Observational studies since the 1980s have suggested a 
protective effect of male circumcision on HIV 
acquisition in men, but could be confounded.    
Inclusion criteria 
Studies:  
Randomized controlled trials 
Participants: 
Sexually active HIV-negative heterosexual men.   
Intervention: 
Male circumcision (surgical removal of the foreskin of 
the penis). 
Outcomes: 
Primary outcome: HIV infection in men (incidence), 
based on laboratory results. 
Secondary outcome: behavioural outcomes, including 
sexual activity. 
Results 
• Three large trials of men from the general population 
were conducted in in South Africa (N = 3274), 
Uganda (N = 4996) and Kenya (N = 2784) between 
2002 and 2006. All three trials were stopped early 
due to significant findings at interim analyses. 
Allocation concealment was inadequate in two trials 
and unclear in one; risk of bias was judged to be low 
to moderate across the three trials. 
• There was a relative risk reduction of acquiring HIV 
of 50% at 12 months and 54% at 21 or 24 months 
following circumcision. There was little statistical 
heterogeneity between the trials’ results. 
• The Kenyan and Ugandan trials showed no 
significant difference in sexual behaviour between 
circumcised and uncircumcised men. In the South 
African trial, the mean number of sexual contacts at 
the 12 month visit was 5.9 in the circumcision group 
versus 5 in the control group, which was a 
statistically significant difference. 
• There were few adverse events following the surgical 
circumcision procedure in all three trials. 
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Does male circumcision prevent heterosexual men 
from acquiring HIV infection? 
Male circumcision reduces HIV acquisition in heterosexual men 
by at least 38%in a two year period.  
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Authors’ conclusions 
Medical male circumcision is a safe procedure and it reduces HIV infection in heterosexual men by at least 38% 
and perhaps up to 66% over 24 months.   
Implications for practice:  
Male circumcision should be implemented as part of current prevention measures if considered feasible, and 
socially and culturally acceptable for local conditions. 
Implications for research: 
Research on the effectiveness of male circumcision for preventing HIV acquisition in heterosexual men is complete 
and no further trials are required. Future research must focus on the effects of male circumcision on the women 
partners of HIV-infected circumcised men, on the feasibility of implementing the procedure into different social and 
cultural contexts, and its cost-effectiveness, as well as its effects on HIV transmission during anal intercourse, both 
in men who have sex with men and between men and women.  
Circumcision offered vs no circumcision: HIV incidence  
 
